Abstract
Magnetic nanoparticles (MNPs), in particular those based on iron oxides, have attracted a lot of attention during the last years for their applications in nanomedicine. This is due to their unique physicochemical properties, such as good biocompatibility, their size in the nanoscale and their superparamagnetism, making them useful for drug delivery, MRI, magnetic targeting and magnetic fluid hyperthermia. Due to these promising properties, important work has also been taking place on MNPs in combination with proteins. MNPs can be used to improve the in vivo properties of therapeutic proteins, increasing their circulation half-lives. On the other hand, proteins are very important candidates to improve the in vivo fate of MNPs, as they can be used for their site-specific active targeting, as well as the enhancement of their colloidal stability in physiological conditions. In this review, we describe the most common preparation methods of protein modified MNPs used for biomedical applications and highlight the most promising ones for each purpose.
Keywords: Magnetic nanoparticles, iron oxide, proteins, therapeutics, active targeting, coating, biomedical applications.
Current Organic Chemistry
Title:Protein-Modified Magnetic Nanoparticles for Biomedical Applications
Volume: 20 Issue: 11
Author(s): Marina Talelli, Antonio Aires and Marzia Marciello
Affiliation:
Keywords: Magnetic nanoparticles, iron oxide, proteins, therapeutics, active targeting, coating, biomedical applications.
Abstract: Magnetic nanoparticles (MNPs), in particular those based on iron oxides, have attracted a lot of attention during the last years for their applications in nanomedicine. This is due to their unique physicochemical properties, such as good biocompatibility, their size in the nanoscale and their superparamagnetism, making them useful for drug delivery, MRI, magnetic targeting and magnetic fluid hyperthermia. Due to these promising properties, important work has also been taking place on MNPs in combination with proteins. MNPs can be used to improve the in vivo properties of therapeutic proteins, increasing their circulation half-lives. On the other hand, proteins are very important candidates to improve the in vivo fate of MNPs, as they can be used for their site-specific active targeting, as well as the enhancement of their colloidal stability in physiological conditions. In this review, we describe the most common preparation methods of protein modified MNPs used for biomedical applications and highlight the most promising ones for each purpose.
Export Options
About this article
Cite this article as:
Talelli Marina, Aires Antonio and Marciello Marzia, Protein-Modified Magnetic Nanoparticles for Biomedical Applications, Current Organic Chemistry 2016; 20 (11) . https://dx.doi.org/10.2174/1385272819666150810221009
DOI https://dx.doi.org/10.2174/1385272819666150810221009 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Electrochemical C-X bond formation
Conventional methods for carrying out carbon–X bond formation are typically conducted at harsh reaction conditions, and rely on expensive catalysts as well as the use of stoichiometric, and perhaps toxic, oxidants. In this regard, electrochemical synthesis has recently been recognized as a sustainable and scalable strategy for the construction of ...read more
From Lab Bench to Algorithm: The Future of Organic Chemistry Powered by AI
Organic chemistry, with its intricate dance of molecules and reactions, is undergoing a transformation fuelled by the power of Artificial Intelligence (AI) and Machine Learning (ML). The integration of AI/ML with Organic Chemistry is revolutionizing the field by enhancing the efficiency and accuracy of chemical research and development. These technologies ...read more
N-Heterocyclics: Synthesis, Computational Studies, and Coordination Chemistry - A synthetic perspective
N-heterocycles, such as phenanthroline, quinoline, or their organometallic complexes, are widely used in a variety of fields, including chemistry, biochemistry, and coordination chemistry. They play a key role in many chemical and biological processes as biological ligands, medicinal agents, catalysts in organic synthesis, molecular probes and sensors, as well as ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Classical and Non-Classical Thyroid Hormone Intracellular Pathways Involved in T Lymphoma Growth
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Brain Perfusion In Sepsis
Current Vascular Pharmacology Translational Gap in Glioma Research
Anti-Cancer Agents in Medicinal Chemistry TGF-β2 Signaling in High-Grade Gliomas
Current Pharmaceutical Biotechnology Dihydromyricetin Reduces TGF-β Via P53 Activation-dependent Mechanism in Hepatocellular Carcinoma HepG2 Cells
Protein & Peptide Letters Targeting Glioma Cells with Nutraceuticals: Therapeutic Effects Based on Molecular Mechanisms, New Evidence and Perspectives
Mini-Reviews in Medicinal Chemistry Current Development of ROS-Modulating Agents as Novel Antitumor Therapy
Current Cancer Drug Targets Advances in the Researches on the Biological Activities and Inhibitors of Phosphatidylinositol 3-kinase
Anti-Cancer Agents in Medicinal Chemistry Association between hTERT Polymorphisms and Female Papillary Thyroid Carcinoma
Recent Patents on Anti-Cancer Drug Discovery Brain Innate Immunity in the Regulation of Neuroinflammation: Therapeutic Strategies by Modulating CD200-CD200R Interaction Involve the Cannabinoid System
Current Pharmaceutical Design DNA Drug Design for Cancer Therapy
Current Pharmaceutical Design Oxidovanadium(IV) Complex Disrupts Mitochondrial Membrane Potential and Induces Apoptosis in Pancreatic Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Natural Products with Antiangiogenic and Antivasculogenic Mimicry Activity
Mini-Reviews in Medicinal Chemistry Pharmacophore-based Identification of Potential Mutant Isocitrate Dehydrogenases I/2 Inhibitors: An Explorative Avenue in Cancer Drug Design
Anti-Cancer Agents in Medicinal Chemistry PPARγ and Early Human Placental Development
Current Medicinal Chemistry Competition Between Tumor and Mononuclear Phagocyte System Causing the Low Tumor Distribution of Nanoparticles and Strategies to Improve Tumor Accumulation
Current Drug Delivery Upregulation of Cytoskeleton Protein and Extracellular Matrix Protein Induced by Stromal-Derived Nitric Oxide Promotes Lung Cancer Invasion and Metastasis
Current Molecular Medicine Targeted Enzyme Prodrug Therapies
Mini-Reviews in Medicinal Chemistry A Rationale for the Use of Proton Pump Inhibitors as Antineoplastic Agents
Current Pharmaceutical Design A Closer Look at α-Secretase
Current Alzheimer Research